dAta-dRiven integrated approaches to CHemIcal safety assessMEnt and Drug dEvelopment

ERC (European Research Council)HORIZON-ERCID: 101043848
EC Contribution
€20,000
Consortium Size
1 orgs
Start Year
2022
Summary

Traditional in vivo tesTraditional in vivo tests are hampering the development of new, safe and effective chemicals and drugs. If on one hand we need to ensure that dangerous chemicals do not emerge, on the other, we also need to promote rapid and sustainable innovation to successfully overcome the modern challenges of humankind. Toxicogenomics aims at clarifying the mechanism of action (MOA) of chemicals by using omics assays. The Adverse Outcome Pathways (AOP) concept is also emerging to contextualise toxicogenomics-derived MOA. Efforts are ongoing to anchor AOPs to molecular assays, but systematic embedding of AOP-derived in vitro tests and Integrated Approaches to Testing and Assessment (IATA) are still unestablished. At the same time, toxicogenomics-based evidence still struggles to gain regulatory acceptance. I aim to implement an integrated strategy based on state-of-the-art big data science, artificial intelligence (AI), toxicogenomics, molecular assays and cell technology via a novel Knowledge Graph approach. I will do so by developing the Toxicology Knowledge Graph (TKG), an innovative data platform where the currently fragmented knowledge in the field is going to be curated and integrated. The TKG will serve as a learning platform for artificial intelligence (AI) algorithms, which will be used to: 1) find new characteristics of chemicals/drugs; 2) infer associations between exposures and diseases; 3) select the most relevant cell lines to study specific phenotypes/chemical classes; 4) find the best genes to be used as reporters for specific AOPs; 5) define the applicability domain of computational, experimental and IATA models. I will also establish and validate regulatory-relevant high-throughput molecular assays to investigate the point of departure (PoD) of exposures. The ARCHIMEDES project will shift the paradigm of chemical and drug development, facilitating the emergence of new, smarter, greener, and more sustainable chemicals, drugs and materials.

Consortium (1)

Project Results (14)

Source: CORDIS, the EU research results database.

Publications (12)
A Multi‐Dimensional Approach to Map Disease Relationships Challenges Classical Disease Views
Advanced Science, Vol 11, Iss 30, Pp n/a-n/a (2024)· 2024DOI
Lena Möbus; Angela Serra; Michele Fratello; Alisa Pavel; Antonio Federico; Dario Greco
A Network Toxicology Approach for Mechanistic Modelling of Nanomaterial Hazard and Adverse Outcomes
Advanced Science, Vol 11, Iss 32, Pp n/a-n/a (2024)· 2024DOI
Giusy del Giudice; Angela Serra; Alisa Pavel; Marcella Torres Maia; Laura Aliisa Saarimäki; Michele Fratello; Antonio Federico; Harri Alenius; Bengt Fadeel; Dario Greco
Knowledge Graphs, Network Models and Health Data Science Approaches for Toxicology and Pharmacology
· 2024
Pavel, Alisa
A curated gene and biological system annotation of adverse outcome pathways related to human health
Scientific Data· 2023DOI
Laura Aliisa Saarimäki; Michele Fratello; Alisa Pavel; Seela Korpilähde; Jenni Leppänen; Angela Serra; Dario Greco
Expanding adverse outcome pathways towards one health models for nanosafety
Frontiers in Toxicology, Vol 5 (2023)· 2023DOI
Laura Aliisa Saarimäki; Laura Aliisa Saarimäki; Giusy del Giudice; Giusy del Giudice; Dario Greco; Dario Greco; Dario Greco
Journal of Translational Medicine
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-13 (2024)· 2023DOI
Antonio Federico; Lena Möbus; Zeyad Al-Abdulraheem; Alisa Pavel; Vittorio Fortino; Giusy del Giudice; Harri Alenius; Nanna Fyhrquist; Dario Greco
KNeMAP: a network mapping approach for knowledge-driven comparison of transcriptomic profiles
Bioinformatics· 2023DOI
Alisa Pavel; Giusy del Giudice; Michele Fratello; Leo Ghemtio; Antonio Di Lieto; Jari Yli-Kauhaluoma; Henri Xhaard; Antonio Federico; Angela Serra; Dario Greco
Nature Nanotechnology
Nature Nanotechnology· 2023DOI
del Giudice G, Serra A, Saarimäki LA, Kotsis K, Rouse I, Colibaba SA, Jagiello K, Mikolajczyk A, Fratello M, Papadiamantis AG, Sanabria N, Annala ME, Morikka J, Kinaret PAS, Voyiatzis E, Melagraki G, Afantitis A, Tämm K, Puzyn T, Gulumian M, Lobaskin V,
The in vitro immunomodulatory effect of multi-walled carbon nanotubes by multilayer analysis
NanoImpact· 2023DOI
Hautanen, Veera; Morikka, Jack; Saarimäki, Laura Aliisa; Bisenberger, Jan; Toimela, Tarja; Serra, Angela; Greco, Dario
The potential of a data centred approach & knowledge graph data representation in chemical safety and drug design
Computational and Structural Biotechnology Journal· 2022DOI
Pavel, Alisa; Saarimäki, Laura A; Möbus, Lena; Federico, Antonio; Serra, Angela; Greco, Dario
Toxicogenomics Data for Chemical Safety Assessment and Development of New Approach Methodologies: An Adverse Outcome Pathway‐Based Approach
Advanced Science· 2022DOI
Saarimäki, Laura Aliisa; Morikka, Jack; Pavel, Alisa; Korpilähde, Seela; del Giudice, Giusy; Federico, Antonio; Fratello, Michele; Serra, Angela; Greco, Dario
Human Genomics
Human Genomics· 2021DOI
Antonio Federico; Alisa Pavel; Lena Möbus; David McKean; Giusy del Giudice; Vittorio Fortino; Hanna Niehues; Joe Rastrick; Kilian Eyerich; Stefanie Eyerich; Ellen van den Bogaard; Catherine Smith; Stephan Weidinger; Emanuele de Rinaldis; Dario Greco
Deliverables (1)
Documents, reports
Other Results (1)
Periodic Reporting for period 1 - ARCHIMEDES (dAta-dRiven integrated approaches to CHemIcal safety assessMEnt and Drug dEvelopment)